Glass Alert in COVID-19 Drug: Gilead’s Swift Recall to Protect Patients
WASHINGTON, D.C. — Gilead Sciences, Inc. (Nasdaq: GILD) has announced a voluntary recall of one lot of its COVID-19 treatment drug, Veklury® (remdesivir) for Injection 100 mg/vial, following the discovery …
Glass Alert in COVID-19 Drug: Gilead’s Swift Recall to Protect Patients Read More